Hims & Hers Health (HIMS) vs. Its Competitors Financial Analysis

Hims & Hers Health (NYSE:HIMS) is one of 60 public companies in the “MEDICAL INFO SYS” industry, but how does it compare to its competitors? We will compare Hims & Hers Health to related companies based on the strength of its risk, profitability, dividends, valuation, earnings, institutional ownership and analyst recommendations.

Volatility & Risk

Hims & Hers Health has a beta of 2.02, meaning that its stock price is 102% more volatile than the S&P 500. Comparatively, Hims & Hers Health’s competitors have a beta of -3.40, meaning that their average stock price is 440% less volatile than the S&P 500.

Profitability

This table compares Hims & Hers Health and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	9.24%	22.75%	15.51%
Hims & Hers Health Competitors	-194.24%	-97.38%	-20.44%

Valuation & Earnings

This table compares Hims & Hers Health and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Hims & Hers Health	$1.48 billion	$126.04 million	73.10
Hims & Hers Health Competitors	$418.60 million	-$61.27 million	5.45

Hims & Hers Health has higher revenue and earnings than its competitors. Hims & Hers Health is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Hims & Hers Health and its competitors, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	3	8	2	0	1.92
Hims & Hers Health Competitors	252	742	1838	24	2.57

Hims & Hers Health presently has a consensus price target of $39.58, suggesting a potential downside of 21.53%. As a group, “MEDICAL INFO SYS” companies have a potential upside of 32.02%. Given Hims & Hers Health’s competitors stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health has less favorable growth aspects than its competitors.

Insider and Institutional Ownership

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 42.3% of shares of all “MEDICAL INFO SYS” companies are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 18.0% of shares of all “MEDICAL INFO SYS” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Hims & Hers Health beats its competitors on 8 of the 13 factors compared.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.